Rocket Lab files prospectus for resale of 2.28M shares linked to Mynaric acquisition

Rocket Lab Corp

Filed prospectus supplement for resale of up to 2,277,002 shares of common stock by selling stockholders.
Shares were issued on April 14, 2026 in connection with the acquisition of Mynaric AG.
Acquisition was previously announced under Stock Purchase Agreement dated September 25, 2025.
Legal opinion from Goodwin Procter LLP filed as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.